Bio-Techne Unveils Innovations in Spatial Biology at NSH Convention for Enhanced Diagnostics

Bio-Techne Advances Spatial Biology with New Technologies at NSH Convention

Bio-Techne Corporation, a prominent player in life science tools, introduces significant advancements in its spatial biology portfolio, focusing on two innovative technologies: RNAscope™ ISH and Lunaphore COMET™. These systems are designed to enhance pathological workflows by enabling the simultaneous detection of RNA and protein biomarkers on the same tissue section. This dual capability is particularly beneficial for bridging the gap between translational research and clinical applications, allowing for a more integrated approach to diagnostics in medicine. The introduction of these technologies marks a pivotal step in refining diagnostic processes, especially in areas where tissue samples are scarce.

The RNAscope™ technology plays a crucial role in identifying clinically relevant biomarkers, such as viral markers and chromosomal translocations, which are essential for accurate disease diagnosis. This platform has been effectively applied in clinical settings, particularly for diagnosing lymphoid malignancies and evaluating B-cell clonality. For example, recent studies demonstrate how RNAscope™ has facilitated the assessment of B-cell clonality through the detection of IGLL5, a critical indicator in understanding the genetic makeup of B-cells. Meanwhile, the COMET™ system enhances spatial multiomic workflows by providing high-throughput analysis capabilities, making it easier for researchers and clinicians to profile complex tissues and obtain results more rapidly.

Bio-Techne’s commitment to advancing diagnostic technology is further underscored by its participation in the National Society of Histotechnology (NSH) Convention, where the company showcases these innovations. Key presentations will feature experts like Dr. Ryan Bremer, who will discuss the advantages of the RNAscope™ technology over traditional diagnostic methods, and Dr. Ishani Das, who will share her findings on B-cell clonality using RNAscope™. Additionally, Dr. Antonio Sorrentino will present on the potential of the COMET technology in diagnosing lymphoid malignancies. These discussions not only highlight the practical applications of Bio-Techne’s tools but also emphasize the company’s dedication to improving diagnostic accuracy and ultimately enhancing patient outcomes in clinical practice.

In other relevant developments, the RNAscope™ and COMET™ technologies demonstrate significant promise in addressing the challenges of limited tissue availability for diagnostic purposes. As healthcare evolves, the integration of advanced spatial biology tools into routine pathology is becoming increasingly essential. Bio-Techne’s innovations are poised to play a critical role in shaping the future of diagnostics, providing researchers and clinicians with powerful means to improve patient care.